Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S. DexCom (NasdaqGS:DXCM) recently received a warning letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback